Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide is a synthetic small molecule featuring a morpholine ring linked to a substituted butyl chain and further functionalized with benzenesulfonyl and phenylethylallyl groups[2][7][10]. It has been catalogued as an experimental compound, with no current clinical or approved therapeutic use. Its structure suggests potential utility in medicinal chemistry research, possibly as an enzyme inhibitor or molecular probe, but there are no published indications of its mechanism of action or specific biological targets. No clinical trials or approved indications have been reported for this molecule[2].
- Other names
- Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-AmideN-[(2R)-1-[[(E,3R)-1-(benzenesulfonyl)-3-methylbutyl]carbamoyl]-2-(phenylethyl)prop-2-enamido]morpholine
Beyond the preview
Go deeper on morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide.